Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/17/2026

Treatment of Asymptomatic Bacteriuria in Pregnancy

Rationale for Treatment

  • Pregnant women with untreated asymptomatic bacteriuria have a significantly higher risk (20-35%) of developing pyelonephritis compared to those who receive treatment (1-4%) 1, 2
  • Untreated asymptomatic bacteriuria is associated with increased risk of preterm delivery and low birth weight infants 2, 3
  • Treatment of asymptomatic bacteriuria reduces the risk of preterm birth from approximately 53 per 1000 to 14 per 1000 2
  • Antimicrobial therapy reduces the risk of very low birth weight from approximately 137 per 1000 to 88 per 1000 2
  • The American College of Obstetricians and Gynecologists and other guideline societies recommend screening for and treatment of asymptomatic bacteriuria during pregnancy as a standard of care in developed countries 1

Screening Recommendations

  • Urine culture should be collected at one of the initial prenatal visits early in pregnancy 2
  • Asymptomatic bacteriuria occurs in 2-7% of pregnant women 2

Treatment Approach

  • For pregnant women with asymptomatic bacteriuria, a 4-7 day course of antimicrobial treatment is recommended 2, 4
  • Nitrofurantoin is often the preferred antibiotic due to its safety profile in pregnancy and effectiveness against common pathogens 4
  • Beta-lactam antibiotics such as ampicillin or cephalexin are safe alternatives during pregnancy 4
  • Single-dose regimens have shown lower rates of bacteriuria clearance compared to short-course regimens and are not recommended 4

Potential Controversies and Caveats

  • The Infectious Diseases Society of America guidelines committee concluded that further evaluation in other populations is necessary before changing the recommendation to screen and treat all pregnant women 2
  • There is insufficient evidence to recommend for or against repeat screening during pregnancy following an initial negative culture or after treatment of an initial episode 2

Follow-up Recommendations

  • After completing antibiotic treatment, a follow-up urine culture is recommended to confirm clearance of the infection 4
  • Some experts recommend continued screening throughout pregnancy after treatment of bacteriuria 3
  • Recurrence is common and may require re-treatment 4

Treatment for Recurrent Asymptomatic Bacteriuria in Pregnancy

Initial Treatment Approach

  • The American College of Obstetricians and Gynecologists and the Infectious Diseases Society of America recommend treating each recurrence of asymptomatic bacteriuria with a 4-7 day course of antibiotics, followed by periodic screening with urine cultures throughout the remainder of pregnancy, to prevent progression to pyelonephritis and adverse pregnancy outcomes 5, 6
  • Antimicrobial therapy is essential to prevent progression to pyelonephritis and adverse pregnancy outcomes in pregnant women with recurrent asymptomatic bacteriuria 7

Management of Recurrence

  • The Infectious Diseases Society of America guidelines explicitly recommend periodic screening for recurrent bacteriuria should be undertaken following therapy as a Grade A-III recommendation, and continue periodic screening with urine cultures throughout pregnancy after any treated episode 5, 6
  • Untreated asymptomatic bacteriuria carries a 20-35% risk of pyelonephritis, reduced to 1-4% with treatment, highlighting the importance of aggressive management in pregnant women 7

Management of Asymptomatic Bacteriuria in Pregnancy

Diagnosis and Screening

Indications for Empiric Treatment

Treatment Protocol

Follow‑up and Recurrence Management

Evidence Strength